Under national guidelines, patients with COVID at high risk of serious illness should be prescribed nirmatrelvir (Paxlovid) by GPs, with the less effective molnupiravir (Lagevrio) a second-line option.
The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?
It’s time to emerge from the ‘bubble of COVID’ and check out what other countries are doing to keep track of vaccination rates and impacts, says paediatrician Associate Professor Nigel Crawford.
When deciding whether to administer Zostavax or not, it’s useful to keep the three types of immunocompromised patients in mind – the mild, the moderate and the severe, says infectious disease physician and virologist Professor Tony Cunningham.
New COVID vaccines are being produced faster than ever before, but the rate of new variants and sub-variants is making it hard to make sure the most up-to-date vaccine is being deployed, says infectious diseases specialist Associate Professor Sanjaya Senanayake.
Recent changes have made prescribing PrEP by any GP on the PBS without the need for special training. HIV positive people without a Medicare Card can now receive free retroviral treatment and monitoring
Here comes the aftermath of the rising COVID numbers, with almost 60% of Australian GPs now saying they are treating at least one patient with long COVID.